Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer’s disease patients
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer’s disease patients
Authors
Keywords
-
Journal
JOURNAL OF NEURAL TRANSMISSION
Volume 119, Issue 7, Pages 771-778
Publisher
Springer Nature
Online
2012-03-09
DOI
10.1007/s00702-012-0780-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers
- (2011) Niklas Mattsson et al. Alzheimers & Dementia
- Altered dopamine modulation of LTD-like plasticity in Alzheimer’s disease patients
- (2010) Giacomo Koch et al. CLINICAL NEUROPHYSIOLOGY
- Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias
- (2010) L. C. de Souza et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- CSF Biomarkers in Prediction of Cerebral and Clinical Change in Mild Cognitive Impairment and Alzheimer's Disease
- (2010) A. M. Fjell et al. JOURNAL OF NEUROSCIENCE
- Revising the definition of Alzheimer's disease: a new lexicon
- (2010) Bruno Dubois et al. LANCET NEUROLOGY
- Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
- (2009) Tero Tapiola et al. ARCHIVES OF NEUROLOGY
- Rapid Progression from Mild Cognitive Impairment to Alzheimer’s Disease in Subjects with Elevated Levels of Tau in Cerebrospinal Fluid and the APOE ε4/ε4 Genotype
- (2009) Elin S. Blom et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Aβ1–42 Detection in CSF of Alzheimer's disease is influenced by temperature: Indication of reversible Aβ1–42 aggregation?
- (2009) Giulia M. Sancesario et al. EXPERIMENTAL NEUROLOGY
- Use of Alzheimer Disease Biomarkers
- (2009) Ronald C. Petersen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
- (2009) Niklas Mattsson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CSF biomarkers predict rate of cognitive decline in Alzheimer disease
- (2009) M. I. Kester et al. NEUROLOGY
- Dopamine Modulates Cholinergic Cortical Excitability in Alzheimer's Disease Patients
- (2009) Alessandro Martorana et al. NEUROPSYCHOPHARMACOLOGY
- G Protein-Coupled Receptors, Cholinergic Dysfunction, and A Toxicity in Alzheimer's Disease
- (2009) A. Thathiah et al. Science Signaling
- Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease
- (2008) Christopher D. Aluise et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Cholinergic Neuronal and Axonal Abnormalities Are Present Early in Aging and in Alzheimer Disease
- (2008) Changiz Geula et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started